GYRE Operating Expenses
Gyre Therapeutics Inc · Operating Expenses
GYRE Operating Expenses
Latest reported$129.25Mperiod ending
GYRE TTM Operating Expenses ($30.64M → $129.25M)
TTM operating expenses
High-resolution chart · PNG
GYRE operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 129,249,000 | |
| 118,813,000 | |
| 107,057,000 | |
| 97,823,000 | |
| 96,109,000 | |
| 86,479,000 | |
| 85,710,000 | |
| 177,142,000 | |
| 174,939,000 | |
| 177,024,000 | |
| 176,044,000 | |
| 81,029,976 | |
| 86,112,044 | |
| 68,482,044 | |
| 65,924,044 | |
| 63,707,068 | |
| 65,667,000 | |
| 79,881,000 | |
| 87,722,000 | |
| 86,219,000 | |
| 77,165,000 | |
| 74,580,000 | |
| 69,110,000 | |
| 64,267,000 | |
| 61,380,000 | |
| 58,484,000 | |
| 57,243,000 | |
| 54,974,000 | |
| 50,124,000 | |
| 42,820,000 | |
| 33,791,000 | |
| 28,254,000 | |
| 22,300,000 | |
| 21,278,000 | |
| 19,035,000 | |
| 18,179,000 | |
| 21,609,000 | |
| 20,578,000 | |
| 20,817,000 | |
| 20,319,000 | |
| 18,492,000 | |
| 17,731,000 | |
| 16,426,000 | |
| -4,856,000 | |
| -24,866,000 | |
| -41,883,000 | |
| -33,416,000 | |
| -3,526,000 | |
| 25,636,000 | |
| 50,878,000 | |
| 50,845,000 | |
| 52,888,000 | |
| 48,608,000 | |
| 53,219,000 | |
| 62,280,000 | |
| 75,926,000 | |
| 95,346,000 | |
| 101,561,000 | |
| 107,382,000 | |
| 103,144,000 | |
| 94,239,000 | |
| 86,861,000 | |
| 72,598,000 | |
| 61,446,000 | |
| 53,318,000 | |
| 49,808,000 | |
| 48,344,000 | |
| 46,825,650 | |
| 47,686,780 | |
| 47,672,320 | |
| 47,480,000 | |
| 47,337,917 | |
| 46,580,007 | |
| 45,876,241 | |
| 42,632,088 | |
| 39,703,037 | |
| 34,864,856 | |
| 29,083,864 | |
| 27,484,002 | |
| 25,150,286 | |
| 26,017,173 | |
| 28,631,484 | |
| 30,639,900 |